Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Faculty who have authored publication Dinaciclib is a novel cyclin-dependent kinase inhibitor with significant clinical activity in relapsed and refractory chronic lymphocytic leukemia.

NameTitleDepartmentInstitution
Samantha M. Jaglowski MD, MPHProfessorMedicineMedical College of Wisconsin